6505--Provide radiopharmaceuticals 36C25625Q0883
Summary
AI-generated · Aug 25, 2025Solicitation requires correcting the Evaluation clause (52.212-2) in the bid package, which will dictate how proposals are scored and compared. This is a procedural update to the evaluation criteria, not a new product requirement, so bidders should review the revised language to understand how offers will be assessed.
Award notice shows MEDEQNOW LLC was funded for radiopharmaceuticals with a final contract value of $3,977,797.20. An earlier entry shows a $0 award amount, indicating a prior placeholder or interim record before the funded award was established.
Correct Provision 52.212-2 Evaluation
From Solicitation posted on May 30, 2025Notice history
2-
-
Award Notice LATEST Posted Jul 15, 2025
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| MEDEQNOW LLC | UUX3F75TKLU4 | 9Z2K0 | SHERIDAN |
Contacts
Contracting Specialist
Phone